COVID-19: do cancer patients have a higher risk of infection?

Written by Rachel Jenkins, Future Science Group

Researchers from Zhongnan Hospital of Wuhan University (Hubei, China) have investigated the incidence and outcomes of COVID-19, a syndrome caused by the novel coronavirus SARS-CoV-2, in cancer patients from a single institution. They have also suggested factors that put cancer patients at a higher risk of developing the virus. A Research Letter, recently published in JAMA Oncology, discusses the findings that highlight the importance of how cancer is managed during the COVID-19 pandemic to reduce the number of patients with cancer developing the viral infection. Read more about the considerations when making cancer treatment decisions during the COVID-19 pandemic here....

To view this content, please register now for access

It's completely free